AIIMS New Delhi has launched Therapeutic Drug Monitoring services for antiepileptic drugs Levetiracetam and Lamotrigine, aiming to provide affordable, precision-based epilepsy care and improve access ...

Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on ...

The pharmacokinetic profile of antiepileptic drugs encompasses absorption, distribution, metabolism and elimination, all of which determine clinical efficacy and safety. Many antiepileptic agents ...

Antiepileptic drugs (AEDs) are prescribed to prevent or reduce the frequency of seizures, yet their use can be accompanied by a range of cognitive side effects. These effects span multiple domains ...

LEVETIRACETAM appeared well tolerated for seizure prophylaxis in octogenarians after severe traumatic brain injury, with low ...

Presentation described the biological rationale for the evaluation of simufilam in TSC-related epilepsyAUSTIN, Texas, May 05, ...

The acquisition involves Angelini Pharma purchasing all outstanding Catalyst shares for $31.50 per share in cash.

Under the definitive agreement, Italian pharmaceutical group will buy all outstanding shares of Catalyst Pharmaceuticals for ...

The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at ...

AIIMS launches advanced Therapeutic Drug Monitoring facility to enhance epilepsy care and accessibility for patients across India.